Latest News for: ose

Edit

OSE Immunotherapeutics Highlights Abstracts Selected for Presentation at ASCO 2025 (OSE Immunotherapeutics SA)

Public Technologies 23 Apr 2025
OSE Immunotherapeutics Highlights Abstracts Selected for ... CET - OSE Immunotherapeutics SA (ISIN ... Tedopi® (OSE-2101) cancer vaccine ... Tedopi® (OSE-2101) cancer vaccine in ARTEMIA Phase 3 trial - OSE IMMUNOTHERAPEUTICS ... ABOUT OSE IMMUNOTHERAPEUTICS.
Edit

Equinor (OSE: EQNR, NYSE: EQNR) suspends offshore construction activities for the Empire Wind project

Nasdaq Globe Newswire 17 Apr 2025
In accordance with a halt work order issued by the US government, Empire Offshore Wind LLC (Empire) will safely halt the offshore construction in waters of the outer continental shelf for the Empire Wind project ... .
Edit

Equinor (OSE: EQNR, NYSE: EQNR) stanser byggingen til havs på Empire Wind-prosjektet (Equinor ASA)

Public Technologies 17 Apr 2025
). The text version of this document is not available ... Disclaimer ... (noodl. 123725666) .
Edit

Equinor (OSE: EQNR, NYSE: EQNR) suspends offshore construction activities for the Empire Wind project (Form 6-K) (Equinor ASA)

Public Technologies 17 Apr 2025
). Equinor (OSE. EQNR, NYSE. EQNR) suspends offshore construction activities for the Empire Wind project ... Empire is engaging with relevant authorities to clarify this matter and is considering its legal remedies, including appealing the order ... Disclaimer.
Edit

Osees’ John Dwyer & Bow Wow Wow’s David Barbarossa Go Deep On Their Wild New Band Chime Oblivion

Stereogum 17 Apr 2025
Nothing like an Osees show, for sure ... And only because I was so fucking busy touring with Osees and writing the Osees record! I have these records that are just sitting off to the side because I simply don’t have time.
Edit

Bill for ailing railway company OSE coming on April 28

Ekathimerini 12 Apr 2025
He said the state of Greek railway operator OSE as “unacceptable.” ... of the European Commission and EODASAM both in terms of train safety and in terms of how OSE will operate,” he said at the Forum.
Edit

Mowi ASA (OSE:MOWI): Q1 2025 Trading update (Mowi ASA)

Public Technologies 11 Apr 2025
). The text version of this document is not available ... Disclaimer ... (noodl.
Edit

OSE Immunotherapeutics to Present Groundbreaking Extension Period Data on Lusvertikimab at DDW 2025

Nasdaq Globe Newswire 09 Apr 2025
OSE Immunotherapeutics to Present Groundbreaking Extension Period Data on Lusvertikimab at DDW 2025. New Clinical Data from Phase 2 Extension Period in Ulcerative Colitis on Long-Term Benefits and Safety of Anti-IL-7R mAb Lusvertikimab ... .
Edit

OSE Immunotherapeutics to Present Groundbreaking Extension Period Data on Lusvertikimab at DDW 2025 (OSE Immunotherapeutics SA)

Public Technologies 09 Apr 2025
OSE Immunotherapeutics to Present Groundbreaking Extension Period Data on Lusvertikimab at DDW 2025 ... CET - OSE Immunotherapeutics SA (ISIN ... ABOUT OSE IMMUNOTHERAPEUTICS ... OSE Immunotherapeutics is based between Nantes and Paris and is quoted on Euronext.
Edit

OSE to steam ahead at private sector-style pace

Ekathimerini 07 Apr 2025
“The goal is to get OSE out of the narrow public sector,” the organization reports.
Edit

Railway staff reappraisals underway, two OSE trainee drug-related dismissals

Ekathimerini 03 Apr 2025
According to OSE, the dismissed individuals were among 109 trainees preparing for station-master positions but had not yet begun their roles. The two men, OSE has informed, were not on the company’s ...
Edit

OSE Immunotherapeutics Presents Preclinical Updates in Immuno-Oncology at AACR Annual Meeting 2025 (OSE Immunotherapeutics SA)

Public Technologies 03 Apr 2025
OSE Immunotherapeutics Presents Preclinical Updates in Immuno-Oncology at AACR Annual Meeting 2025 OSE-CYTOMASK®, a new CIS-Demasking 1 cytokine bispecific technology ... CET - OSE Immunotherapeutics SA (ISIN ... ABOUT OSE IMMUNOTHERAPEUTICS.
Edit

03/04/2025 OSE Immunotherapeutics Presents Preclinical Updates in Immuno-Oncology at AACR Annual Meeting 2025 (OSE Immunotherapeutics SA)

Public Technologies 03 Apr 2025
OSE Immunotherapeutics Presents Preclinical Updates in Immuno-Oncology at AACR Annual Meeting 2025. • OSE-CYTOMASK®, a new CIS-Demasking1 cytokine bispecific technology ... CET - OSE Immunotherapeutics SA (ISIN ... ABOUT OSE IMMUNOTHERAPEUTICS.
Edit

Lokotech Group AS (OSE: LOKO) Meldingspliktig handel (Lokotech Group AS)

Public Technologies 02 Apr 2025
). The text version of this document is not available ... Disclaimer ... (noodl. 123434994) .
×